Celestica Closes $3.39B Follow-On Offering After Underwriters Exercise Full Over-Allotment
CLS sits 83% above its 52-week low of $173.23.
Summary
Celestica closed a $3.39 billion follow-on offering, selling 11.1 million shares at $310 each after underwriters exercised the full over-allotment option. The proceeds will fund AI infrastructure investments, but the deal dilutes existing shareholders by roughly 9–10%.
Key Events · Financing and Capital Events · CLS
-
Offering Closed with Full Over-Allotment
Celestica sold 9,677,419 firm shares plus 1,451,612 option shares at $310 per share, generating total gross proceeds of approximately $3.45 billion and net proceeds of ~$3.39 billion after fees.
-
Dilution Impact
The 11.1 million new shares represent roughly 9–10% of the pre-offering share count—a significant dilution for existing shareholders—though the capital infusion strengthens the balance sheet.
-
Use of Proceeds
Proceeds are earmarked for working capital and capital expenditures to support AI infrastructure investments, aligning with the company's hyperscaler-driven growth strategy.
-
Insider Lock-Ups
Sixteen executives and directors, including the CEO and CFO, signed 60-day lock-up agreements, restricting sales of their shares until early October 2026.
Analysis · CLS · Manufacturing
Celestica has finalized its massive $3 billion follow-on offering, with underwriters exercising the full over-allotment option to bring total shares sold to 11.1 million and net proceeds to approximately $3.39 billion. Priced at $310 per share—a 16.5% discount to the last close before announcement—the deal underscores the urgency to raise capital for AI infrastructure investments. The dilution is significant: the new shares represent roughly 9–10% of the pre-offering share count, yet the proceeds nearly double the company's cash position, funding aggressive expansion in data center and networking markets. A 60-day lock-up for 16 insiders signals alignment, though the CEO recently sold $36.3 million under a 10b5-1 plan. Coming on the heels of a strong Q2 earnings beat and raised guidance, the transaction suggests the company is capitalizing on a high stock price to fuel growth.
At the time of this filing, CLS was trading at $316.65 on NYSE in the Manufacturing sector, with a market capitalization of approximately $36.5B. The 52-week trading range was $173.23 to $474.03. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.